Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to ameliorate interleukin-18-induced cardiac hypertrophy.
about
Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18.Pan-histone deacetylase inhibitors regulate signaling pathways involved in proliferative and pro-inflammatory mechanisms in H9c2 cellsTrichostatin A induces a unique set of microRNAs including miR-129-5p that blocks cyclin-dependent kinase 6 expression and proliferation in H9c2 cardiac myocytes.High-density lipoprotein inhibits mechanical stress-induced cardiomyocyte autophagy and cardiac hypertrophy through angiotensin II type 1 receptor-mediated PI3K/Akt pathway.CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.Histone Deacetylase Inhibitor Phenylbutyrate Exaggerates Heart Failure in Pressure Overloaded Mice independently of HDAC inhibition.Improving understanding of chromatin regulatory proteins and potential implications for drug discovery.IL-6 Activates PI3K and PKCζ Signaling and Determines Cardiac Differentiation in Rat Embryonic H9c2 Cells.CD38 promotes angiotensin II-induced cardiac hypertrophy.Histone deacetyltransferase inhibitors Trichostatin A and Mocetinostat differentially regulate MMP9, IL-18 and RECK expression, and attenuate Angiotensin II-induced cardiac fibroblast migration and proliferation.Reversible Notch1 acetylation tunes proliferative signalling in cardiomyocytes.
P2860
Q29347157-AA1CC575-803D-4346-AEED-52782E869E74Q34515132-D4D1CE42-7700-4CFF-81BF-44EAD98EE156Q35946789-9D612BD7-F884-43E3-947C-82E98AFBAC22Q35995098-7FA1B1AF-D260-4063-AE39-0C3A17E16E6EQ36337179-086E9D27-909D-457A-B1E3-2B5647FBE8CFQ37281996-36DE714F-3DEA-4F64-A045-0FBBB370A559Q38753861-CABE9759-D699-4AF3-89BA-1CF6071EE5B4Q38849864-FFA473FC-0518-486E-8E27-7583173DEB3CQ41241222-D9CB226A-5787-4074-8196-A0D9B40D54ECQ42494392-EC6CB6D3-BFB5-4747-B2ED-F9610FFCD4FEQ47302478-504B8DFD-33D4-4F5A-B87C-10B454B0E3A7
P2860
Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to ameliorate interleukin-18-induced cardiac hypertrophy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Panhistone deacetylase inhibit ...... 8-induced cardiac hypertrophy.
@ast
Panhistone deacetylase inhibit ...... 8-induced cardiac hypertrophy.
@en
type
label
Panhistone deacetylase inhibit ...... 8-induced cardiac hypertrophy.
@ast
Panhistone deacetylase inhibit ...... 8-induced cardiac hypertrophy.
@en
prefLabel
Panhistone deacetylase inhibit ...... 8-induced cardiac hypertrophy.
@ast
Panhistone deacetylase inhibit ...... 8-induced cardiac hypertrophy.
@en
P2093
P2860
P1476
Panhistone deacetylase inhibit ...... 8-induced cardiac hypertrophy.
@en
P2093
Gipsy Majumdar
I Maria Johnson
Rajendra Raghow
Robert J Rooney
P2860
P304
P356
10.1152/PHYSIOLGENOMICS.00048.2011
P577
2011-09-27T00:00:00Z